Surgery Partners Stock

Surgery Partners ROA

The Return on Assets (ROA) of Surgery Partners (SGRY) as of Jul 26, 2026 is -0.95 %. In the previous year, Return on Assets (ROA) was -2.13 % — a change of -55.64% (higher).

ROA

-0.95 %

YoY

-55.64%

Last updated:

In 2026, Surgery Partners's return on assets (ROA) was -0.95 %, a -55.64% increase from the -2.13 % ROA in the previous year.

Access this data via the Eulerpool API

Surgery Partners Stock analysis

What does Surgery Partners do? Surgery Partners Inc is an American company specializing in specialized surgical services in the United States. It was founded in 1997 and is headquartered in Nashville, Tennessee. The company focuses on outpatient surgical procedures, providing a variety of medical services including eye surgery, endoscopy, ENT surgery, gynecology, orthopedic surgery, plastic surgery, and urology. Surgery Partners has over 180 surgical centers and practices in 32 states. It expanded its services through the acquisition of Symbion Healthcare in 2017, offering anesthesia services, pain management, diagnostics, and laboratory services. The company also emphasizes excellent service and has partnerships with hospitals to expand its surgical services. Surgery Partners is one of the most popular companies on Eulerpool.

ROA Details

Understanding Surgery Partners's Return on Assets (ROA)

Surgery Partners's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Surgery Partners's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Surgery Partners's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Surgery Partners’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Surgery Partners stock

Return on Assets (ROA) of Surgery Partners is -0.95 % in 2026.

Access this data via the Eulerpool API

Profitability — Surgery Partners

All Key Metrics — Surgery Partners